Shopping Cart
Remove All
Your shopping cart is currently empty
Laromustine (VNP40101M) is a sulfonyl hydrolytic alkylating prodrug used in cancer therapy with significant anticancer activity.
Inhibiting thioredoxin reductase can be used to study acute myeloid leukemia.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $293 | - | In Stock | |
| 5 mg | $722 | - | In Stock | |
| 10 mg | $987 | - | In Stock | |
| 25 mg | $1,520 | - | In Stock | |
| 50 mg | $1,980 | - | In Stock |
| Description | Laromustine (VNP40101M) is a sulfonyl hydrolytic alkylating prodrug used in cancer therapy with significant anticancer activity. Inhibiting thioredoxin reductase can be used to study acute myeloid leukemia. |
| Targets&IC50 | CYP2B6:125 mM (Ki), CYP3A4/5:297 mM (Ki), CYP2C19:349 mM (ki) |
| In vitro | Laromustine caused direct inhibition of CYP2B6 and CYP3A4/5 as well as of CYP2C19. CYP2B6 K(i)=125 mM, CYP3A4/5 K(i)=297 mM, and CYP2C19 K(i)=349 mM and were greater than the average clinical plasma C(max) of Laromustine (C(max)=25 mM). [1] |
| Synonyms | VNP40101M, VNP 40101M |
| Molecular Weight | 307.78 |
| Formula | C6H14ClN3O5S2 |
| Cas No. | 173424-77-6 |
| Smiles | O=C(NC)N(N(CCCl)S(=O)(=O)C)S(=O)(=O)C |
| Color | White |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.